Patent ID: 9133458
Filing Date: 2015-09-15
Classification: A61K,A61P,C12N

Abstract:
1. A method for the treatment of hepatitis B infection or hepatitis B/hepatitis D co-infection, the method comprising administering to a patient in need of such treatment one or more first pharmaceutically acceptable agent or agents consisting of: an oligonucleotide chelate complex: comprising the following: and one or more second pharmaceutically acceptable immunotherapeutic agent or agents consisting of: thymosin α1; interferon α-2a; interferon α-2b; interferon α-N3; interferon β-1a; interferon β-1b; interferon γ-1b; interferon λ1; interferon λ2; interferon λ3; pegylated interferon α-2a; pegylated interferon α2b; pegylated interferon λ1; pegylated interferon λ2; GS-9620 (4-amino-2-butoxy-8[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one); dehydroepiandrosterone; androstenediol; or androstenetriol.